0001829126-23-006437.txt : 20231004
0001829126-23-006437.hdr.sgml : 20231004
20231004164050
ACCESSION NUMBER: 0001829126-23-006437
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230913
FILED AS OF DATE: 20231004
DATE AS OF CHANGE: 20231004
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sire Group Ltd.
CENTRAL INDEX KEY: 0001995392
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13341
FILM NUMBER: 231308546
BUSINESS ADDRESS:
STREET 1: NO. 4, FRANKY BUILDING
STREET 2: PROVIDENCE INDUSTRIAL ESTATE
CITY: MAHE
STATE: T2
ZIP: 00000
BUSINESS PHONE: 6012 484 4444
MAIL ADDRESS:
STREET 1: NO. 4, FRANKY BUILDING
STREET 2: PROVIDENCE INDUSTRIAL ESTATE
CITY: MAHE
STATE: T2
ZIP: 00000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shen Seow Gim
CENTRAL INDEX KEY: 0001995393
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13341
FILM NUMBER: 231308545
MAIL ADDRESS:
STREET 1: NO. 4, FRANKY BUILDING
STREET 2: PROVIDENCE INDUSTRIAL ESTATE
CITY: MAHE
STATE: T2
ZIP: 00000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000910267
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943171940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502444990
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
3
1
ownership.xml
FORM 3
X0206
3
2023-09-13
0
0000910267
TITAN PHARMACEUTICALS INC
TTNP
0001995392
Sire Group Ltd.
NO. 4, FRANKY BUILDING,
PROVIDENCE INDUSTRIAL ESTATE
MAHE
T2
00000
SEYCHELLES
0
0
1
0
0001995393
Shen Seow Gim
NO. 4, FRANKY BUILDING,
PROVIDENCE INDUSTRIAL ESTATE
MAHE
T2
00000
SEYCHELLES
0
0
1
0
Common Stock
20836266
D
Series AA Convertible Preferred Stock ("Preferred Stock")
0.466
2023-09-13
Common Stock
20836266
D
The total number of shares into which the Preferred Stock ultimately is convertible is as set forth in the table, but the Preferred Stock contains restrictions limiting the number of converted shares that the reporting persons may have at any one time, without Issuer stockholder approval, to 3,001,757 shares.
Seow Gim Shen owns the shares beneficial ownership is indirect, by virtue of his sole ownership of The Sire Group Ltd., which owns the shares directly.
Not Applicable
THE SIRE GROUP LTD, By: /s/ Seow Gim Shen, Chief Executive Officer
2023-10-04
/s/ Seow Gim Shen
2023-10-04